Bordeaux Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$338K Buy
13,939
+3,377
+32% +$78.8K 0.04% 119
2025
Q1
$268K Sell
10,562
-2,812
-21% -$73.6K 0.05% 127
2024
Q4
$355K Buy
13,374
+1,470
+12% +$39.9K 0.06% 107
2024
Q3
$345K Buy
11,904
+1,775
+18% +$51.8K 0.06% 113
2024
Q2
$283K Buy
+10,129
New +$279K 0.05% 113
2024
Q1
Sell
-7,423
Closed -$214K 122
2023
Q4
$214K Buy
7,423
+12
+0.2% +$363 0.07% 104
2023
Q3
$246K Buy
7,411
+589
+9% +$20.8K 0.1% 83
2023
Q2
$250K Sell
6,822
-12,907
-65% -$502K 0.1% 84
2023
Q1
$805K Sell
19,729
-625
-3% -$27K 0.41% 38
2022
Q4
$1.04M Sell
20,354
-636
-3% -$30.5K 0.57% 24
2022
Q3
$919K Buy
20,990
+414
+2% +$20.1K 0.58% 30
2022
Q2
$1.08M Sell
20,576
-1,743
-8% -$88.8K 0.74% 25
2022
Q1
$1.16M Buy
22,319
+1,817
+9% +$94.3K 0.62% 29
2021
Q4
$1.21M Buy
20,502
+1,665
+9% +$82.5K 0.56% 31
2021
Q3
$810K Sell
18,837
-159
-0.8% -$7.04K 0.46% 35
2021
Q2
$744K Buy
18,996
+1,000
+6% +$38.9K 0.43% 38
2021
Q1
$652K Hold
17,996
0.45% 34
2020
Q4
$662K Buy
+17,996
New +$660K 0.5% 31

Other funds holding PFE

Bordeaux Wealth Advisors's PFE Position: Q2 2025 in Review

Bordeaux Wealth Advisors increased its Pfizer (PFE) stake by 32% in Q2 2025, buying an estimated $78.8K and bringing the position to 13,939 shares worth $338K. The position accounts for 0.04% of the portfolio, ranked #119.

Bordeaux Wealth Advisors first reported a position in PFE in Q4 2020 and has held it in 18 quarters since. The position peaked at $1.21M in Q4 2021. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Bordeaux Wealth Advisors held 13,939 shares of Pfizer worth $338K as of Q2 2025.
  • Bordeaux Wealth Advisors bought 3,377 Pfizer shares in Q2 2025, an estimated $78.8K.
  • Pfizer made up 0.04% of Bordeaux Wealth Advisors's portfolio in Q2 2025, its #119 holding.
  • Bordeaux Wealth Advisors first reported a position in Pfizer in Q4 2020 and has held it in 18 quarters since.
  • Bordeaux Wealth Advisors's Pfizer position peaked at $1.21M in Q4 2021.
  • 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Bordeaux Wealth Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.